Search

everythinglearnresearchcommunity

for

Search:↓

Loop diuretics may double bone loss in elderly men, finasteride lowers prostate cancer risk but may increase high-grade tumors, abarelix reduces testosterone quickly, and transdermal testosterone offers minimal sexual benefit for women.

Ritlecitinib is safe and may effectively treat alopecia areata.

Steroid sulfatase inhibitors could potentially treat hormone-related disorders like certain cancers, hair loss, acne, and improve cognitive dysfunction.

Spironolactone does not increase cancer risk and may lower prostate cancer risk, but more research is needed.

Intravenous and oral calcium effectively treated vitamin D dependent rickets type II, improving growth and bone health.

Spironolactone reduced hair thickness and some testosterone levels in women with excessive hair growth.

Continued ritlecitinib treatment can improve hair regrowth in some alopecia areata patients who initially don't respond.

New compounds were made that block an enzyme linked to breast cancer better than existing treatments.

A girl with Becker's nevus syndrome showed good improvement in breast development using spironolactone.

Proactive monitoring and management are essential to maximize the benefits of Trastuzumab Deruxtecan while minimizing serious side effects.

A teenage girl's excessive hair growth was caused by a medication for mania, but improved after stopping the medication.

Flutamide is more effective and has fewer side effects than spironolactone for treating hirsutism.

A rare genetic mutation causes resistance to vitamin D, leading to severe rickets and requires high doses of calcium and vitamin D for management.

Oral spironolactone effectively promotes hair growth in premenopausal women but may cause irregular menstruation.

Ritlecitinib is effective and safe for treating severe alopecia areata in people aged 12 and older.

A patient with Rhupus was diagnosed with Rowell syndrome and treated with various medications.

Trilostane generally improved symptoms in dogs with Cushing's syndrome, but dosage adjustments were needed over time.

Spironolactone may reduce excessive hair growth in women.

Trastuzumab deruxtecan is effective for advanced breast cancer but has side effects like nausea and fatigue.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

Ritlecitinib helps regrow hair in alopecia areata and is safe for long-term use.

Risankizumab effectively treats and maintains skin clearance in moderate-to-severe psoriasis.

Eplerenone, a mineralocorticoid receptor antagonist, was found to promote hair growth in human hair follicles.

Spironolactone may help treat excessive hair growth in girls, but more research is needed.

Ritlecitinib works well and is safe for treating alopecia areata.

Trilostane effectively improved symptoms in dogs with a certain adrenal gland disorder.

Spironolactone may help reduce hair loss in androgenic alopecia.